The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases

被引:242
作者
Giasson, BI
Ischiropoulos, H
Lee, VMY
Trojanowski, JQ
机构
[1] Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[2] Univ Penn, Stokes Res Inst, Childrens Hosp Philadelphia, Philadelphia, PA USA
[3] Univ Penn, Stokes Res Inst, Dept Biochem & Biophys, Philadelphia, PA USA
基金
加拿大健康研究院;
关键词
Alzhiemer's disease; alpha-synuclein; nitration; oxidative stress; Parkinson's disease; tau; free radicals;
D O I
10.1016/S0891-5849(02)00804-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's (AD) and Parkinson's diseases (PD) are late-onset neurodegenerative diseases that have tremendous impact on the lives of affected individuals, their families, and society as a whole. Remarkable efforts are being made to elucidate the dominant factors that result in the pathogenesis of these disorders. Extensive postmortem studies suggest that oxidative/nitrative stresses are prominent features of these diseases, and several animal models support this notion. Furthermore, it is likely that protein modifications resulting from oxidative/nitrative damage contribute to the formation of intracytoplasmic inclusions characteristic of each disease. The frequent presentation of both AD and PD in individuals and the co-occurrence of inclusions characteristic of AD and PD in several other neurodegenerative diseases suggests the involvement of a common underlying aberrant process. It can be surmised that oxidative/nitrative stress, which is cooperatively influenced by environmental factors, genetic predisposition, and senescence, may be a link between these disorders. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:1264 / 1275
页数:12
相关论文
共 196 条
[1]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[2]   OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[3]  
AMICI A, 1989, J BIOL CHEM, V264, P3341
[4]   Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid [J].
Ando, Y ;
Brännström, T ;
Uchida, K ;
Nyhlin, N ;
Näsman, B ;
Suhr, O ;
Yamashita, T ;
Olsson, T ;
El Salhy, M ;
Uchino, M ;
Ando, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 156 (02) :172-176
[5]  
[Anonymous], 1996, Ann Neurol, V39, P37
[6]   Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [J].
Ara, J ;
Przedborski, S ;
Naini, AB ;
Jackson-Lewis, V ;
Trifiletti, RR ;
Horwitz, J ;
Ischiropoulos, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7659-7663
[7]   Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein [J].
Arawaka, S ;
Saito, Y ;
Murayama, S ;
Mori, H .
NEUROLOGY, 1998, 51 (03) :887-889
[8]  
Baba M, 1998, AM J PATHOL, V152, P879
[9]  
Baumgarten HG, 2000, EXPT CLIN NEUROTOXIC, P659
[10]   HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827